Benzinga | Feb 4, 2021 09:03AM EST

cbdMD Highlights Retaining Of Former FDA Official Dr. Sibyl Swift As A Regulatory Consultant

cbdMD, Inc. (NYSE:YCBD, YCBDpA))))) (the "Company"), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has retained former US Food and Drug Administration (FDA) official Dr. Sibyl Swift as a regulatory consultant to oversee the company's regulatory initiatives and prepare its products for further certifications.